Page 4 - Thomas Ichim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Creative Medical Technology Holdings Announces Successful Application of ImmCelz® Immunotherapy for Treatment of Stroke Company Plans to Leverage Existing AmnioStem® Expertise for Novel Approach to Protecting and Regenerating Injured Brains News provided by Share this article Share this article PHOENIX, Dec. 16, 2020 /PRNewswire/ -- Creative Medical Technology Holdings Inc., (OTC – CELZ) announced today positive preclinical data supporting the utilization of its ImmCelz® cell based immunotherapy for treatment of stroke.  In an animal model of ischemia stroke, the middle cerebral artery...

Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy Clinical Stage Cell Therapy Company Reports Concurrent Modulation of T Regulatory Cells and Tolerogenic Dendritic Cells using Adoptive Cellular Therapy News provided by Share this article Share this article PHOENIX, Dec. 10, 2020 /PRNewswire/ -- Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company's ImmCelz ® product at gen...